Target intelligence / Profile preview

Intracellular myocardial components

Molecular classification
Other, Intracellular proteins and organelles
01

Overview

Intracellular myocardial components refer to the collective internal structures of cardiomyocytes, including myofibrils, mitochondria, the sarcoplasmic reticulum, and various cytosolic proteins [DrugBank, PubMed]. These components are fundamental to the heart's ability to contract and maintain rhythmic electrical activity; myofibrils provide mechanical force, while mitochondria generate ATP through oxidative phosphorylation [PubMed]. The sarcoplasmic reticulum regulates calcium levels, which is crucial for excitation-contraction coupling, and disruption of these components is a hallmark of various cardiomyopathies and heart failure [PubMed]. In a pharmacological context, these components serve as the target for specific diagnostic radiopharmaceuticals, such as Technetium Tc-99m pyrophosphate, which localize in areas of myocardial damage [DrugBank, StatPearls]. Following an acute myocardial infarction, the loss of cell membrane integrity allows these agents to enter the cell and bind to calcium deposits (hydroxyapatite) and denatured proteins within the necrotic tissue [StatPearls]. This interaction is also utilized in the diagnosis of transthyretin cardiac amyloidosis, where the tracer binds to amyloid fibrils deposited within the myocardial interstitium and intracellular spaces [StatPearls]. While not a single molecular entity, these components are critical for maintaining cardiac function and serve as essential markers for diagnostic imaging [DrugBank, StatPearls].

Other names
Myocardial intracellular componentsIntracellular cardiac componentsNecrotic myocardial tissue components
02

Mechanism of action

Binding to calcium hydroxyapatite crystals and denatured proteins within necrotic or damaged myocardial cells [StatPearls, DrugBank].

03

Biological functions

Muscle contractionEnergy metabolismIon homeostasisCalcium signaling
04

Disease associations

Myocardial infarctionCardiac amyloidosisHeart failureCardiomyopathy
05

Safety considerations

Radiation exposureNon-specific binding in bone or soft tissueFalse positive results in chronic injury
06

Interacting drugs

Technetium Tc-99m pyrophosphate

1 more in the full profile.

07

Biomarkers

Cardiac troponin ICardiac troponin TCreatine kinase-MB

Beyond the preview

Go deeper on Intracellular myocardial components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular myocardial components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call